A

Amylyx Pharmaceuticals

Biopharmaceutical company developing neurodegenerative therapies

Associate Director - CMC, Program Management

Program ManagementPosted on Nov 12
Full-timeRemote in USA

About the Job

Requirements

  • A bachelor's degree in life sciences, chemistry, engineering, pharmaceutical sciences, or a related discipline is required.
  • Eight to ten years of relevant pharmaceutical or biotechnology industry experience is required, including significant project or program management supporting CMC, Technical Operations, manufacturing, or product development.
  • Understanding of CMC development, regulatory CMC requirements, and cGMP-compliant pharmaceutical development and manufacturing is required.
  • Experience building and managing complex integrated plans across multiple technical workstreams, including timelines, milestones, dependencies, risks, budgets, and resource requirements, is required.
  • Ability to lead cross-functional teams and drive execution through influence in a matrixed environment without relying on direct authority is required.
  • Experience proactively identifying, communicating, escalating, and managing program risks, issues, decisions, and competing priorities is required.
  • Strong written, verbal, facilitation, stakeholder-management, analytical, and organizational skills, including the ability to communicate technical and program information clearly to different audiences, are required.
  • Proficiency with project-management and collaboration tools used to maintain plans, trackers, dashboards, actions, and program documentation is required.

Responsibilities

  • Lead program management for one or more CMC programs by developing and maintaining integrated plans covering scope, timelines, milestones, dependencies, deliverables, resources, budgets, and key decision points.
  • Partner with CMC asset leads and functional subject matter experts to translate CMC strategy into coordinated execution plans supporting development, manufacturing, lifecycle management, regulatory filings, and program objectives.
  • Lead CMC team meetings and governance processes, including agendas, minutes, action-item tracking, decision logs, risk registers, and escalation of issues requiring leadership attention.
  • Monitor critical-path activities, identify strategic and operational risks, assess downstream impacts, and partner with stakeholders to develop mitigation and contingency plans.
  • Coordinate CMC deliverables across Regulatory, Quality, Analytical Development, Technical Development, and Supply Chain, ensuring clear ownership, accountability, and communication across workstreams.
  • Develop concise program dashboards and status reports providing visibility into milestones, risks, decisions, budget status, resource needs, and overall CMC readiness.
  • Support planning and execution of complex CMC initiatives, including technical transfers, process development and validation activities, regulatory submission readiness, and lifecycle-management programs.
  • Establish and continuously improve scalable CMC program-management tools, templates, metrics, meeting structures, and ways of working to strengthen execution across the broader CMC organization.

Desired Qualifications

  • A master's degree in a scientific, engineering, or business discipline is preferred.
  • Direct experience supporting CMC programs from early development through late-stage development and commercialization readiness is preferred.
  • Project Management Professional certification or an equivalent project or program management credential is preferred, along with experience using tools such as Smartsheet, Microsoft Project, or SharePoint.

About the Company

Amylyx Pharmaceuticals

Biopharmaceutical company developing neurodegenerative therapies

Amylyx Pharmaceuticals develops treatments for neurodegenerative diseases, with a focus on ALS and Alzheimer's disease. Its main asset is AMX0035, currently in clinical trials, including the CENTAUR study for ALS and the PEGASUS study for late mild cognitive impairment or early dementia due to Alzheimer’s disease. The company advances products through rigorous, randomized, double-blind, placebo-controlled trials to demonstrate safety and efficacy before pursuing commercialization. In addition to research, Amylyx engages in awareness and community campaigns to support patients, caregivers, and researchers. The company aims to bring validated therapies to market to improve patient outcomes and generate revenue by selling treatments to healthcare providers and patients.

Company size
51-200
Company stage
IPO
Headquarters
Cambridge, MA
Founded
2013

Recently Posted Jobs

Explore more opportunities at Amylyx Pharmaceuticals

See more jobs